Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma — Stella

Home/Congenital Hyperinsulinism/Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

View on ClinicalTrials.gov

Recruiting

Back to Congenital Hyperinsulinism trials

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Cook Children's Medical Center, Fort Worth, Texas

Key details

Phase

Early testing

Sponsor

Cook Children's Health Care System

Enrollment target

~250 participants

Started

October 2013

Primary completion

January 2028

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.